Document is current
Any future updates will be listed below
-
Authors
Liu, Nan https://orcid.org/0000-0002-5291-3077
Zhou, Qiuping https://orcid.org/0000-0002-3935-555X
Wang, Huifang https://orcid.org/0000-0003-0305-2861
Li, Qian https://orcid.org/0000-0001-5357-8357
Chen, Zhuo https://orcid.org/0000-0002-2776-2908
Lin, Yiyan https://orcid.org/0000-0002-4851-2502
Yi, Lingling https://orcid.org/0000-0001-6142-7997
Jiang, Shuqi https://orcid.org/0000-0001-7474-7551
Chen, Chunbo https://orcid.org/0000-0001-5662-497X
Deng, Yiyu https://orcid.org/0000-0002-0459-7399
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82272189)
Key Research and Development projects of the Ministry of science and technology (2021YFC2501802)
Natural Science Foundation of Guangdong Province (2019A1515010206)
Guangzhou Municipal Science and Technology Project (202002030094)
High-level Hospital Construction Project (DFJH201804)
- License Information
-
More Information
Article History
Received: 14 February 2023
Accepted: 20 June 2023
First Online: 21 July 2023
Declarations
:
: The authors declare that they have no competing interests.
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for the publication of the images in Table .
: All animals were handled according to the protocols of the Institutional Animal Care and Use Committee, Guangdong Province, China (Animal Certificate No.: SYXK2012-0081). The human CSF specimen was conducted following the Declaration of Helsinki and was approved by the Research Ethics Committee of Guangdong Province’s General Hospital (KY-Q-2022-176-02).
: We declared that a limitation in the study was the lack of testing of the specificity of the primary antibodies.
